Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination.

Mäkilä, T; Jeskanen, L; Butina, M; Harjama, L; Ranki, A; Mälkönen, T; Kluger, N

Mäkilä, T; Jeskanen, L; Butina, M; Harjama, L; Ranki, A; Mälkönen, T; Kluger, N.

Mäkilä T; Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Jeskanen L; Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Butina M; Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Harjama L; Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Ranki A; Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Mälkönen T; Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Kluger N; Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

J Eur Acad Dermatol Venereol ; 36(6): e431-e433, 2022 06.

Article in English | MEDLINE | ID: covidwho-1703935

Subject(s)

COVID-19; Pityriasis Lichenoides; COVID-19/prevention & control; Chronic Disease; Humans; Recurrence; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pityriasis Lichenoides / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18024

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google